LiPlasome, a biotech company focused on oncology, provides a liplasomal reformulation of anticancer drugs on the market.
Business Model:
Revenue: $2M
Employees: 11-50
Address: Venlighedsvej 1
City: Hørsholm
State: other
Zip: 2970
Country: DK
LiPlasome is a Danish privately owned biotech company focusing on oncology. The LiPlasome technology provides a liplasomal reformulation of the most used anticancer drugs on the market like Cispaltin -&g; LiPlaCis®, Oxaliplatin -&g; LiPloxa. The aim is to provide more effective treatment to cancer patients with fewer side effects.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 3/2005 | Series B | $0 |
BankInvest Biomedical Venture Incuba Venture Vecata BankInvest Biomedical Venture Incuba Venture Vecata |
3/2005 | Series B | 3 | $8M |
BankInvest Biomedical Venture Incuba Venture Vecata BankInvest Biomedical Venture Incuba Venture Vecata |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|